DONATE
News /

BLINK exhibition wins global design award

May 2020
Lady looking at degrading image in art gallery

An interactive photo exhibition which provides an artistic representation of sight loss from blinding trachoma has been given an award.

Sightsavers’ temporary exhibition BLINK – The End is in Sight was recognised at the Drum Design awards in the category of ‘Experiential Design’ and was highly commended in the ‘Design for Good’ category. Judges at the Design Awards, which recognise the latest innovation and creativity in marketing and communications, said the exhibition created a unique way of showing the devastating impact of trachoma.

The exhibition featured the work of famous photographers, including fashion photographer Nick Knight; the late David Goldblatt; and photojournalists Kate Holt, Georgina Cranston and Tommy Trenchard. They were all asked to donate images of a sight they would miss if they were to lose their vision.

It was held at London’s iconic OXO gallery in October 2019 and gave visitors an insight into what it’s like to live with trachoma, a neglected tropical disease that causes a slow and painful deterioration in eyesight. The infection starts like conjunctivitis but if left untreated, can cause years of agony as the eyelashes turn inward and scratch the eyeball – irreversibly damaging eyesight.

Sightsavers trachoma doctor checking eyes in remote village

The End is in Sight

We’re on a mission to end the pain and devastation of trachoma and save millions from the threat of going blind.

Join the fight

MET Studio, alongside Barker Langham and Jason Bruges Studio, helped to develop the exhibition. They created an interactive experience that provided an artistic illustration of the sight loss associated with trachoma. The digital photographs on display slowly deteriorated over the course of the exhibition, triggered by the blinks of those viewing them – the more blinks, the greater the rate of decay. By the end of the exhibit, the photographs were almost unrecognisable.

Ella Pierce, Sightsavers’ director of fundraising and marketing, said: “BLINK was a bold exhibition that shone a creative light on avoidable sight loss through trachoma. We’re really proud to have won this award and are grateful for the support of the amazing creative agencies who were the driving force behind this exciting event.”

In areas with limited access to healthcare, such as rural parts of Africa, people infected with trachoma often turn to homemade methods of dealing with the pain and discomfort, like plucking out their eyelashes every few days. The disease can force people to give up their livelihoods and become reliant on members of the family or community.

Sightsavers’ End is in Sight campaign is working across Africa and Asia to eliminate trachoma. The infection can be cured with antibiotic treatments costing as little as 15 pence and in the later stages of the disease, a quick operation can fix the discomfort and often restore sight – and people’s livelihoods.

A yellow image featuring the Blink logo.

Take the audio tour

Take a virtual trip round the exhibit with our audio guide to the gallery.

Listen now

Read all our latest news stories

News from Sightsavers
A volunteer drug distributor washing hands washes someone's hands.
sightsavers_news

Trachoma treatments resume in Nigeria after COVID-19 lockdown

Nigeria is the first Sightsavers-supported country to resume treatments for neglected tropical diseases (NTDs) since April due to COVID-19.

September 2020
A volunteer inspects a baby's eyes for signs of trachoma.
sightsavers_news

Commonwealth Fund protects 10 million people from trachoma

Sightsavers and partners delivered 11.7 million trachoma treatments and carried out nearly 32,000 trichiasis surgeries in two years under the Commonwealth Fund.

September 2020
A community volunteer distributed treatment to protect against neglected tropical diseases to a woman.
sightsavers_news

Health programme exceeds several first-year targets

A Sightsavers-led programme in Africa has surpassed several of its first-year targets as it delivers more than 127 million drug treatments for five debilitating neglected tropical diseases (NTDs).

September 2020

Learn about our work to save sight